INTRODUCTION {#sec1-1}
============

Laparoscopic sleeve gastrectomy (LSG) is the most common bariatric surgical procedures done worldwide. *De novo* gastro-oesophageal reflux disease (GERD) after LSG is reported in the range of 0%--34.9%.\[[@ref1][@ref2]\] The common long-term complications after LSG include symptoms of reflux, features of endoscopic oesophagitis and Barrett\'s oesophagus.\[[@ref1]\] A lower oesophageal peptic stricture after LSG is extremely rare and according to our knowledge, this has not been reported till date. We, with this present the first case of oesophageal peptic stricture post-sleeve gastrectomy and its management.

CASE REPORT {#sec1-2}
===========

A 64-year-old man, who underwent LSG, 8 years back, presented to the bariatric outpatient with increasing intensity of reflux symptoms past 3 months. His pre-surgery upper gastrointestinal endoscopy was normal, with no signs of a hiatus hernia. Endoscopic examination revealed Grade D oesophagitis (Los-Angeles classification). A four quadrant biopsy around the GE junction showed mild chronic oesophagitis. The patient was put on proton pump inhibitors (PPI), twice daily. After 6 weeks, his dyspepsia subsided but started to have dysphagia for solids. On repeat endoscopy, a stricture was evident, 32 cm from the incisors with erythema and ulceration. The endoscope was not negotiable beyond the narrowing \[[Figure 1](#F1){ref-type="fig"}\]. Contrast-enhanced CT of abdomen and chest showed circumferential wall thickening of 1.6 cm, measuring 3.5 cm in length, at the gastro-oesophageal junction \[[Figure 2](#F2){ref-type="fig"}\], along with a solitary lymph node. The endoscopic biopsy was suggestive of reflux oesophagitis without dysplasia.

![Endoscopic picture showing lower oesophageal stricture at 32 cm from the incisors](JMAS-16-282-g001){#F1}

![Computed tomography coronal picture showing oesophageal wall thickening](JMAS-16-282-g002){#F2}

Endoscopic ultrasonography was done to rule out the possibility of malignancy. The patient received balloon dilatation up to 14 mm controlled radial expansion (CRE), in the same setting. Further treatment options in the form of prolonged PPI therapy, regular surveillance followed by dilatation against revisional procedure, were discussed with the patient. Accordingly, a laparoscopic revisional Roux-en-Y Gastric bypass (RYGB) was planned.

Intraoperatively, after adhesiolysis, sleeved stomach was assessed, which was non-dilated. The division of phreno-oesophageal fascia revealed laxity of hiatus with a small hernia, which was repaired with crurorrhaphy. The biliopancreatic and alimentary limb lengths were 50 and 100 cm respectively, given the primary intent of anti-reflux procedure rather than weight loss. The procedure lasted 90 min, was uneventful. The patient accepted clear liquids on post-operative day (POD) 01 and was discharged on POD 03 along with PPI twice daily therapy.

The patient received two sets of endoscopic CRE balloon dilation (through-the-scope oesophageal balloon dilator, Boston Scientific, MA, USA) up to 13.5 mm and 15 mm at one and 2 months' follow-up, respectively. The patient has completed a 1-year follow-up after last dilatation, is currently asymptomatic.

DISCUSSION {#sec1-3}
==========

*De novo* GERD following LSG has a reported incidence ranging from (0% to 30%).\[[@ref1][@ref2]\] A study reported *de novo* reflux symptoms in 23%, with the incidence of oesophagitis and Barrett\'s changes in 5.5% and 1.2%, respectively.\[[@ref1]\] The overall incidence of stricture following LSG has been reported to be 0.1%--3.9%. Dysphagia post-LSG was found to be in 22.7%, of which the stricture, mostly in the mid-body (54.5%) and incisura (30.2%) in the sleeve was found to be in 2.3% cases.\[[@ref3]\]

The management of peptic oesophageal stricture consists of medical therapy with PPI, endoscopic dilatation and surgical management. Therapeutic endoscopic interventions include balloon dilatations at intervals of a 4--6 weeks, four-quadrant injection of Triamcinolone (40 mg/cc) (0.5cc/quadrant) and by the use of Self-expanding stents.\[[@ref4][@ref5][@ref6]\] Newer endoscopic methods such as LINX™ (Torax Medical Inc., Shoreview, MN, United States), reflux management procedure system (magnetic sphincter device) and STRETTA™ procedure (Maderi Therapeutics Inc., Norwalk, United States), have been used as anti-reflux endoscopic measures with variable results.\[[@ref7]\]

Laparoscopic RYGB owing to its anti-reflux property is considered the procedure of choice for treating obesity and GERD. It is equally effective in the management of *de novo* reflux after other procedures.\[[@ref8]\] There is evidence of good clinical and endoscopic response with almost complete remissions.\[[@ref9]\] Other surgical options in this setting are revisional sleeve gastrectomy, seromyotomy, hiatoplasty and anterior fundoplication especially in patients with dilated fundus following LSG.\[[@ref10]\]

CONCLUSION {#sec1-4}
==========

Benign peptic stricture in the lower oesophagus due to reflux after sleeve gastrectomy is rare. Conversion RYGB along with optimal usage of serial dilatation and medical therapy can provide definitive relief.
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